Skip to main content

Want a detailed portfolio tracker?

Annexon (ANNX) P/E (2020 - 2026)

Annexon (ANNX) P/E from Sep 30, 2020 to Jul 21, 2026. The TTM Annexon (ANNX) P/E is -4.17. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Annexon (ANNX)

YearP/EChange
2026-4.17+9.16%
2025-3.82-17.23%
2024-4.61+96.31%
2023-2.35+50.76%
2022-1.56-70.77%
2021-5.33-91.27%
2020-61.07N/A

Comparison Annexon (ANNX) P/E with competitors

Annexon (ANNX) P/E is -4.17.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.10%
ENLVEnlivex Ltd0.07-101.80%
FGENFibroGen Inc0.24-105.76%
CHRSCoherus Biosciences Inc0.85-120.37%
FBIOFortress Biotech Inc0.95-122.78%
ORMPOramed Pharmaceuticals Inc1.50-136.08%
AGENAgenus Inc3.01-172.25%
INVAInnoviva Inc3.15-175.72%
VXRTVaxart Inc3.55-185.22%
CRMDCorMedix Inc3.63-187.11%
CVACCureVac N.V.4.45-206.73%
GLPGGalapagos NV4.86-216.65%
SRPTSarepta Therapeutics Inc4.88-217.21%
ABEOAbeona Therapeutics Inc5.39-229.34%
ABUSArbutus Biopharma Corp5.60-234.34%
ZVRAZevra Therapeutics Inc5.89-241.34%
SPROSpero Therapeutics Inc6.23-249.53%
CGENCompugen Ltd6.31-251.58%
RIGLRigel Pharmaceuticals6.87-264.98%
SLXNSilexion Therapeutics Corp7.30-275.16%
OMEROmeros Corporation9.26-322.28%
AUPHAurinia Pharmaceuticals Inc9.58-330.11%
PLXProtalix BioTherapeutics Inc10.89-361.46%
ACADAcadia Pharmaceuticals Inc11.73-381.57%
TBPHTheravance Biopharma Inc12.26-394.38%
ADMAAdma Biologics Inc12.42-398.13%
HRMYHarmony Biosciences Holdings Inc13.82-431.79%
SABSSAB Biotherapeutics Inc14.14-439.37%
NAGENiagen Bioscience Inc14.82-455.75%
INCYIncyte Corp15.82-479.86%
REGNRegeneron Pharmaceuticals Inc15.86-480.68%
PBYIPuma Biotechnology Inc17.32-515.71%
CPRXCatalyst Pharmaceuticals Inc17.44-518.67%
EXELExelixis Inc17.54-521.04%
TGTXTG Therapeutics Inc18.97-555.33%
MDXGMimedx Group Inc20.55-593.41%
XOMAXOMA Royalty Corp22.87-649.18%
ARGXArgen X SE24.30-683.35%
CTMXCytomX Therapeutics Inc24.82-695.91%
XOMAOXOMA Royalty Corp25.34-708.48%
HALOHalozyme Therapeutics Inc25.62-715.18%
XOMAPXOMA Royalty Corp25.67-716.29%
VRTXVertex Pharmaceuticals Inc27.99-772.10%
RPRXRoyalty Pharma plc - Class A28.69-788.73%
SLNOSoleno Therapeutics Inc29.02-796.60%
ASNDAscendis Pharma A/S30.09-822.30%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1010.20%
APLSApellis Pharmaceuticals Inc39.02-1036.83%
BMRNBiomarin Pharmaceutical Inc42.21-1113.43%
KRYSKrystal Biotech Inc45.34-1188.61%
ONCBeiGene Ltd69.54-1769.53%
PHARPharming Group N.V.75.03-1901.22%
TECHBio-Techne Corp101.96-2547.83%
VCELVericel Corp109.92-2739.00%
ALNYAlnylam Pharmaceuticals Inc117.96-2932.12%
GMABGenmab140.29-3468.12%
TLXTelix Pharmaceuticals Ltd162.15-3992.98%
CORTCorcept Therapeutics Inc212.86-5210.31%